CompuGroup Medical SE Financials

CompuGroup Medical Stock Summary

CompuGroup Medical competes with Drägerwerk, Medartis Holding, Nipro Corp, Luye Pharma, and Kaken Pharmaceutical. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.

CompuGroup Medical Key Financial Ratios

There are many critical financial ratios that CompuGroup Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CompuGroup Medical reports annually and quarterly.

CompuGroup Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CompuGroup Medical's current stock value. Our valuation model uses many indicators to compare CompuGroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuGroup Medical competition to find correlations between indicators driving CompuGroup Medical's intrinsic value. More Info.CompuGroup Medical SE is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CompuGroup Medical SE is roughly  3.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuGroup Medical's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of CompuGroup Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CompuGroup Medical SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of CompuGroup Medical SE based on widely used predictive technical indicators. In general, we focus on analyzing CompuGroup Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CompuGroup Medical's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

If you are still planning to invest in CompuGroup Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CompuGroup Medical's history and understand the potential risks before investing.